Increased RUNX1 mutations in breast cancer disease progression
Despite advances in screening, therapy and surveillance, breast cancer remains threatening to women. Worst, patients suffer from side effects of treatments and cancer cells become resistant. The emergence of RUNX1 in breast cancer has put it in a spotlight due to its roles in the disease progression...
| Published in: | Pathology Research and Practice |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier GmbH
2024
|
| Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85182566156&doi=10.1016%2fj.prp.2023.155076&partnerID=40&md5=a5d9823a4a1026341b14ccad47b54349 |